The sales are routine and immaterial — insiders exercised options and sold a portion to cover taxes. Monitor for any material news (earnings, pipeline updates) that might have prompted the option exercises, but the dollar amounts are too small to signal a bearish view.
Price Chart
Executive Summary
Two C-suite insiders at Nurix Therapeutics sold a combined $107K in open-market shares on April 30, 2026, following derivative exercises at $0 cost. The sales are routine tax-related dispositions tied to option exercises and represent only ~0.006% of the $1.7B market cap, making them immaterial.
Key Financial Metrics
Key Facts
- Chief Scientific Officer Gwenn Hansen sold 3,214 shares at $16.65 for $53K on April 30, 2026
- Chief Legal Officer Christine Ring sold 3,214 shares at $16.65 for $53K on April 30, 2026
- Both insiders simultaneously exercised 2,000 options each at $0 exercise price (non-cash events)
- Total open-market sales of $107K represent ~0.006% of NRIX's $1.7B market cap
- CFO Hans van Houte also sold 2,388 shares for $40K on the same day (part of the cross-filing cluster)
- No insider buying in the cluster; all open-market activity is selling
Financial Impact
Total insider sales of $107K, negligible relative to $1.7B market cap
Risk Factors
- No material risk from this cluster given the trivial dollar amounts
- If a larger insider selling pattern emerges in coming weeks, it could warrant attention
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1777585136515 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 29d ago | Insider Cluster | $25.32 $25.10 | ▼ −0.87% | ▲ +0.28% | $22.89 (−9.60%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.22 $27.19 | ▲ +7.81% | ▲ +6.60% | $22.89 (−9.24%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.89 (−8.88%) |
Aug 3, 2026 8w ago | Insider Cluster | $24.69 $25.96 | ▲ +5.14% | ▲ +5.24% | $22.89 (−7.29%) |
Jul 30, 2026 9w ago | Insider Cluster | $23.21 $25.53 | ▲ +10.00% | ▲ +6.48% | $22.89 (−1.38%) |
Jul 9, 2026 12w ago | Press Release | $23.06 $23.07 | ▲ +0.04% | ▲ +0.60% | $22.89 (−0.74%) |
Jul 2, 2026 13w ago | Insider Cluster | $23.97 $24.69 | ▲ +3.00% | ▲ +2.07% | $22.89 (−4.51%) |
Jun 11, 2026 16w ago | Institutional Cluster | $16.98 $17.12 | ▲ +0.82% | ▲ +0.39% | $22.89 (+34.81%) |
Jun 8, 2026 16w ago | 8-K | $15.64 $17.04 | ▲ +8.95% | ▲ +6.84% | $22.89 (+46.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access